The COVID-19 pandemic, and the ensuing response by the medical establishment, was an eye-opening experience for tens of millions of Americans. We watched as the medical establishment put the biopharmaceutical complex’s bottom line above the health and well-being of the American people. Sadly, greed in medicine isn’t new and it isn’t restricted just to pandemic responses. Indeed, greed is often the primary motivation for much of our medical establishment’s response to almost every single healthcare challenge we face. This is certainly the case when it comes to the fight against cancer: A recent study in the journal Cancer takes a closer look at the impact of cancer drug prices on pharma revenues. Dr. Daniel Meyers at the University of Calgary and colleagues looked at the total revenue generated by ten
Dr. McCullough Reveals the Cancer-Fighting Drug Big Pharma Doesn’t Want You to Know About
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!